Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Rheumatoid Arthritis

Free Subscription Articles published in Rheumatol Int Retrieve available abstracts of 122 articles: HTML format

Single Articles

September 2025
1. ANIL C, Akaltun MS, Altindag O, Gur A, et al
   Reduced forearm muscle thickness and hand strength in patients with rheumatoid arthritis: an ultrasonographic cross-sectional study.
   Rheumatol Int. 2025;45:238.
   PubMed     Abstract available
   
   
   
2. WILLIAMS JC, Rogers K, Southworth J, Hum RM, et al
   High prevalence and distinct patterns of metabolic syndrome in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a population-based study.
   Rheumatol Int. 2025;45:239.
   PubMed     Abstract available
   
   
   
3. ZEKIC T, Blazic F, Katalinic N, Cizmarevic NS, et al
   Methotrexate and biological therapy are not associated with fatty liver in rheumatoid arthritis-a cross-sectional study.
   Rheumatol Int. 2025;45:236.
   PubMed     Abstract available
   
   
   
4. PATIL H, Prasad S, Subramanian R, Mamadapur M, et al
   Methotrexate-induced pancytopenia: clinical characteristics, medication errors, and outcomes in a tertiary care centre: a retrospective single-centre study.
   Rheumatol Int. 2025;45:235.
   PubMed     Abstract available
   
   
   
5. DUBEY S, Peddasomayajulu A, Nandagudi A, Maw W, et al
   Enhanced education and support needs in rheumatoid arthritis associated interstitial lung disease (RA-ILD) - patient experiences from a multicentre UK survey.
   Rheumatol Int. 2025;45:237.
   PubMed     Abstract available
   
   
   
6. NAKAPHAN P, Pajareya P, Jansem P, Phutinart S, et al
   Diagnostic accuracy of anti-carbamylated protein antibodies in rheumatoid arthritis: a systematic review and meta-analysis.
   Rheumatol Int. 2025;45:232.
   PubMed     Abstract available
   
   
   
7. GULER T, Yurdakul FG, Ataman S, Akgul O, et al
   The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry.
   Rheumatol Int. 2025;45:222.
   PubMed     Abstract available
   
   
   
8. AKGOZ A, Yakut Y, Tufekci O, Aktas BE, et al
   Biopsychosocial model-based exercise improves muscle strength, proprioception, pain, function, and quality of life in rheumatoid arthritis patients with knee involvement: a randomized controlled clinical tiral.
   Rheumatol Int. 2025;45:221.
   PubMed    
   
   
   
9. RYBARCZYK M, Koszela K, Manczak M, Gasik R, et al
   Change in the angle of cervical lordosis after occipito-cervical fixation in the course of instability of C1-C2 in patients with rheumatoid arthritis.
   Rheumatol Int. 2025;45:213.
   PubMed     Abstract available
   
   
   August 2025
10. POTOCKA W, Assy Z, van Tilborg MMA, Bikker FJ, et al
    Association between dry mouth and dry eyes: a systematic literature review of clinical evidence.
    Rheumatol Int. 2025;45:209.
    PubMed     Abstract available
    
    
    
11. MIROCHA G, Makowska J, Brzezinska O
    Risk factors of nociplastic pain in patients with autoimmune arthritis: web-based cross-sectional survey of patients.
    Rheumatol Int. 2025;45:205.
    PubMed     Abstract available
    
    
    
12. TORRENTE-SEGARRA V, Huizinga T, Salomon-Escoto K, Da Silva JP, et al
    Biological DMARD survival in rheumatoid arthritis patients in clinical practice: a METEOR registry data analysis.
    Rheumatol Int. 2025;45:190.
    PubMed    
    
    
    
13. NEGRON JB, Lopez-Olivo MA, Carmona L, Christensen R, et al
    The advocacy effect: a grounded theory study on the inclusion of caregivers or nearest support persons in research to better understand patient outcomes in rheumatoid arthritis.
    Rheumatol Int. 2025;45:188.
    PubMed     Abstract available
    
    
    
14. KARADAG DT, Gokcen N, Yazici A, Cefle A, et al
    Approaches to screening for rheumatoid arthritis-associated interstitial lung disease: a cross-sectional national survey of Turkish rheumatologists.
    Rheumatol Int. 2025;45:187.
    PubMed     Abstract available
    
    
    
15. NOSSENT JC, Keen HI, Preen DB, Inderjeeth CA, et al
    Epidemiology and complications of rheumatoid arthritis in the Indigenous Australian population.
    Rheumatol Int. 2025;45:185.
    PubMed     Abstract available
    
    
    
16. RUSINOVICH-LOVGACH O, Plaza Z, Fernandez-Castro M, Rosas-Gomez de Salazar J, et al
    High incidence of lymphoma in Sjogren's disease: predictors and mortality implications in a prospective cohort study.
    Rheumatol Int. 2025;45:184.
    PubMed     Abstract available
    
    
    
17. CHEN G, Mansoor M
    Letter to the editor: social determinants of health in managing late-onset rheumatoid arthritis.
    Rheumatol Int. 2025;45:180.
    PubMed    
    
    
    
18. CALVO-ARANDA E, Novella-Navarro M
    Cardiovascular vasculopathy in gout and rheumatoid arthritis: a shared perspective.
    Rheumatol Int. 2025;45:179.
    PubMed    
    
    
    July 2025
19. JAKUBASZEK M, Kwiatkowska B, Plaza M, Maslinska M, et al
    Anti-citrullinated protein antibodies may be prognostic factor for vascularization of the synovial membrane in patients with high activity of RA.
    Rheumatol Int. 2025;45:172.
    PubMed     Abstract available
    
    
    
20. KOCYIGIT BF, Zimba O, Yessirkepov M, Khojakulova U, et al
    Rheumatoid hand massage therapy to mitigate sarcopenia and improve patients' quality of life: a hypothesis.
    Rheumatol Int. 2025;45:173.
    PubMed     Abstract available
    
    
    
21. CROMIE DAJ, Stewart SK, Wright GD, Healy EG, et al
    Rheumatoid vasculitis presenting in the absence of rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2025;45:168.
    PubMed     Abstract available
    
    
    June 2025
22. MURPHY L, Murphy G, Cornally N, McHugh S, et al
    Low adherence to cardiovascular risk assessment guidelines in patients with rheumatoid arthritis: a retrospective chart review of routine clinical practice.
    Rheumatol Int. 2025;45:158.
    PubMed     Abstract available
    
    
    
23. FEDORCHENKO Y, Zimba O, Qumar AB, Yessirkepov M, et al
    Physical activity of older patients with rheumatoid arthritis.
    Rheumatol Int. 2025;45:157.
    PubMed     Abstract available
    
    
    
24. FERNANDEZ-CASTRO M, Plaza-Almuedo Z, Rosas J, Martinez-Taboada V, et al
    Long-term changes in Sjogren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry.
    Rheumatol Int. 2025;45:156.
    PubMed     Abstract available
    
    
    
25. GAVAN SP, Chang S, Rivellese F, Ide Z, et al
    Estimating pain visual analogue scale from health assessment questionnaire for rheumatoid arthritis with beta mixture models.
    Rheumatol Int. 2025;45:154.
    PubMed     Abstract available
    
    
    
26. ZIMBA O, Baimukhamedov C, Kocyigit BF
    Late-onset rheumatoid arthritis: clinical features, diagnostic challenges, and treatment approaches.
    Rheumatol Int. 2025;45:152.
    PubMed     Abstract available
    
    
    May 2025
27. BRYANT MJ, Lester S, Russell O, Whittle S, et al
    Implementation of a novel patient reported experience measure (PREM) in rheumatology: a cross-sectional online survey of Australian rheumatology outpatients.
    Rheumatol Int. 2025;45:138.
    PubMed     Abstract available
    
    
    
28. LOPEZ C, Parisi S, Parasiliti-Caprino M, Beccuti G, et al
    Disease activity score is associated with vertebral fragility fractures in patients with rheumatoid arthritis: a cross-sectional multidisciplinary study.
    Rheumatol Int. 2025;45:133.
    PubMed     Abstract available
    
    
    April 2025
29. KONAL O, Bolen F, Guvenc TS, Pehlivan O, et al
    Gout and rheumatoid arthritis are associated with subclinical vascular damage, reduced brachial vasoreactivity and coronary microvascular dysfunction: a case-control study.
    Rheumatol Int. 2025;45:117.
    PubMed     Abstract available
    
    
    
30. KIRIK A, Sahin N, Baykul M, Bodur H, et al
    Low vaccination rates and awareness status in patients with rheumatoid arthritis: a nationwide cross-sectional survey study.
    Rheumatol Int. 2025;45:116.
    PubMed     Abstract available
    
    
    
31. BOUR S, Goossens L, Khidir S, de Jong P, et al
    The natural course of health-related quality of life in patients with clinically suspect arthralgia: a longitudinal study in progressors and non-progressors to rheumatoid arthritis.
    Rheumatol Int. 2025;45:112.
    PubMed     Abstract available
    
    
    
32. ANYFANTI P, Angeloudi E, Pagkopoulou E, Boutel M, et al
    Effects of treatment with janus kinase inhibitors on coronary microvascular perfusion in patients with rheumatoid arthritis: an observational prospective cohort study.
    Rheumatol Int. 2025;45:111.
    PubMed     Abstract available
    
    
    
33. KARPOUZAS GA, Ormseth SR, Van Riel P, Myasoedova E, et al
    Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study.
    Rheumatol Int. 2025;45:106.
    PubMed     Abstract available
    
    
    
34. ZENGIN ACEMOGLU SS, Bircan AO, Turk I, Coskun Benlidayi I, et al
    Increased fear of falling in primary Sjogren's syndrome: kinesiophobia, impaired balance and poor sleep quality as triggering factors.
    Rheumatol Int. 2025;45:97.
    PubMed     Abstract available
    
    
    
35. RISSER LM, Witte T, Englbrecht M, Strunz PP, et al
    Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.
    Rheumatol Int. 2025;45:100.
    PubMed     Abstract available
    
    
    
36. KUSZMIERSZ P, Gula Z, Strach M, Nowakowski J, et al
    Work productivity and activity impairment in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a comparative analysis from the POLNOR-Rheuma cohort.
    Rheumatol Int. 2025;45:96.
    PubMed     Abstract available
    
    
    
37. BENAVENT D, Carmona L, Garcia Llorente JF, Montoro M, et al
    Artificial intelligence to predict treatment response in rheumatoid arthritis and spondyloarthritis: a scoping review.
    Rheumatol Int. 2025;45:91.
    PubMed     Abstract available
    
    
    
38. SUZUKI K, Akiyama M, Shimanuki K, Kaneko Y, et al
    Radiological extent predicts prognosis and relapse after acute exacerbation of interstitial lung disease in patients with rheumatoid arthritis: KEIO-RA-cohort.
    Rheumatol Int. 2025;45:92.
    PubMed     Abstract available
    
    
    
39. FIERRO JJ, Schoots MH, Liefers SC, der Meer BD, et al
    Immunohistochemical analysis reveals higher Myxovirus resistance protein 1 expression and increased macrophage count in placentas from patients with systemic rheumatic diseases.
    Rheumatol Int. 2025;45:90.
    PubMed     Abstract available
    
    
    March 2025
40. BRZEZINSKA O, Cieplucha A, Slodkowski K, Lewandowska-Polak A, et al
    The incidence of hypersensitivity to non-steroid anti-inflammatory drugs in the group of patients with rheumatoid musculoskeletal disorders: the cross-sectional study.
    Rheumatol Int. 2025;45:82.
    PubMed     Abstract available
    
    
    
41. KHOJAKULOVA U, Yessirkepov M, Zimba O, Fedorchenko Y, et al
    Massage therapy in rheumatoid arthritis.
    Rheumatol Int. 2025;45:76.
    PubMed     Abstract available
    
    
    February 2025
42. FLOOD M, Ni Gabhann-Dromgoole J, Tynan G, Dillon N, et al
    Use of complementary and alternative medicine (CAM) among people living with Sjogren's: a cross-sectional survey using a modified international CAM questionnaire (I-CAM-Q).
    Rheumatol Int. 2025;45:55.
    PubMed     Abstract available
    
    
    
43. LINDGREN LH, Hammer NM, Flurey CA, Jensen KV, et al
    Gender differences in illness acceptance and coping strategies among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis: a cross-sectional survey study.
    Rheumatol Int. 2025;45:52.
    PubMed     Abstract available
    
    
    
44. FEDORCHENKO Y, Yessirkepov M, Doskaliuk B, Zaiats L, et al
    Thyroid disease as a comorbidity in inflammatory rheumatic diseases.
    Rheumatol Int. 2025;45:46.
    PubMed     Abstract available
    
    
    
45. BERTHELOT W, Sirois C, Julien AS, Amiable N, et al
    The association between polypharmacy and disease control in rheumatoid arthritis and systemic lupus erythematosus: a cohort study.
    Rheumatol Int. 2025;45:44.
    PubMed     Abstract available
    
    
    
46. PFEUFFER N, Hartmann F, Grahammer M, Simon D, et al
    Early detection of rheumatoid arthritis through patient empowerment by tailored digital monitoring and education: a feasibility study.
    Rheumatol Int. 2025;45:43.
    PubMed     Abstract available
    
    
    January 2025
47. GOKCEN N, Komac A, Tuncer Kuru F, Ozdemir Isik O, et al
    Inadequate sleep hygiene as a key factor in poor sleep quality in systemic sclerosis: an observational, cross-sectional study.
    Rheumatol Int. 2025;45:40.
    PubMed     Abstract available
    
    
    
48. POLAK D, Korkosz M, Gula Z
    Sleep disorders in rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis.
    Rheumatol Int. 2025;45:36.
    PubMed     Abstract available
    
    
    
49. JASKOLSKA M, Rytlewska M, Dulak NA, Ulanowski M, et al
    Diversity of central nervous system manifestations in Sjogren's Disease: a case-based review.
    Rheumatol Int. 2025;45:35.
    PubMed     Abstract available
    
    
    
50. PRASANNA H, Inderjeeth CA, Nossent JC, Almutairi KB, et al
    The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rheumatol Int. 2025;45:34.
    PubMed     Abstract available
    
    
    
51. AUSSERWINKLER M, Gensluckner S, Frey V, Gostner I, et al
    Cerebrovascular risk in rheumatoid arthritis patients: insights from carotid artery atherosclerosis in the Paracelsus 10,000 study.
    Rheumatol Int. 2025;45:33.
    PubMed     Abstract available
    
    
    
52. SWEENEY M, Carpenter L, de Souza S, Caton E, et al
    Self-management behaviors do not affect remission but mediate between mental health and disease outcomes in a longitudinal study of rheumatoid arthritis.
    Rheumatol Int. 2025;45:31.
    PubMed     Abstract available
    
    
    
53. GULA Z, Krzysciak W, Kuszmiersz P, Bystrowska B, et al
    Higher serotonin levels among patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis compared to healthy controls assessed by liquid chromatography-tandem mass spectrometry (LC-MS).
    Rheumatol Int. 2025;45:17.
    PubMed     Abstract available
    
    
    December 2024
54. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
    Discontinuation of biologic and target-specific therapy in patients with rheumatoid arthritis: a retrospective cohort study.
    Rheumatol Int. 2024;45:6.
    PubMed     Abstract available
    
    
    
55. WINTER L, Petzinna SM, Skowasch D, Pizarro C, et al
    Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study.
    Rheumatol Int. 2024;45:3.
    PubMed     Abstract available
    
    
    
56. SUZUKI K, Akiyama M, Takei H, Kaneko Y, et al
    Successful rituximab treatment in a seronegative rheumatoid arthritis patient with concurrent cold agglutinin syndrome and immune thrombocytopenia.
    Rheumatol Int. 2024;45:2.
    PubMed     Abstract available
    
    
    
57. BRIX L, Hedemann-Nielsen A, Medrud L, Fredberg U, et al
    Joint swelling in the hand in rheumatoid arthritis: agreement between clinical evaluation, ultrasonography, magnetic resonance imaging and patient self-evaluation.
    Rheumatol Int. 2024;45:1.
    PubMed     Abstract available
    
    
    
58. BOURNIA VK, Fragoulis GE, Mitrou P, Tsolakidis A, et al
    Increased prevalence of inflammatory arthritis, systemic lupus erythematosus and systemic sclerosis, during 2020-2023 versus 2016-2019 in a Nation-Wide Cohort Study.
    Rheumatol Int. 2024;44:2837-2846.
    PubMed     Abstract available
    
    
    
59. XU Z, Han T, Cheng L, Fan J, et al
    The real experience of reporting electronic patient-reported outcomes in patients with inflammatory arthritis and factors influencing participation: a scoping review.
    Rheumatol Int. 2024;44:2795-2806.
    PubMed     Abstract available
    
    
    
60. ANTON J, Mosquera JM, Calzada J, Iglesias E, et al
    Similarities and differences between systemic juvenile idiopathic arthritis and adult-onset Still's disease: a multicenter Spanish study.
    Rheumatol Int. 2024;44:2911-2920.
    PubMed     Abstract available
    
    
    
61. PRASAD CB, Kopp CR, Naidu G, Sharma V, et al
    Overlap syndrome of anti-aquaporin 4 positive neuromyelitis optica spectrum disorder and primary Sjogren's syndrome: a systematic review of individual patient data.
    Rheumatol Int. 2024;44:2807-2815.
    PubMed     Abstract available
    
    
    November 2024
62. LEE JS, Oh JS, Kim S, Kim YJ, et al
    The association of obesity and the risk of rheumatoid arthritis according to abdominal obesity status: a nationwide population-based study in Korea.
    Rheumatol Int. 2024 Nov 22. doi: 10.1007/s00296-024-05748.
    PubMed     Abstract available
    
    
    
63. GULA Z, Losinska K, Kuszmiersz P, Strach M, et al
    A comparison of comorbidities and their risk factors prevalence across rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis with focus on cardiovascular diseases: data from a single center real-world cohort.
    Rheumatol Int. 2024 Nov 11. doi: 10.1007/s00296-024-05740.
    PubMed     Abstract available
    
    
    
64. DEY M, Doskaliuk B, Parodis I, Lindblom J, et al
    COVID-19 vaccination-related delayed adverse events among people with rheumatoid arthritis: results from the international COVAD survey.
    Rheumatol Int. 2024 Nov 6. doi: 10.1007/s00296-024-05742.
    PubMed     Abstract available
    
    
    October 2024
65. UHRENHOLT L, Sorensen MER, Lauridsen KB, Duch K, et al
    Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
    Rheumatol Int. 2024;44:1897-1908.
    PubMed     Abstract available
    
    
    
66. HINKEMA HJ, Westra J, Arends S, Brouwer E, et al
    Higher levels of markers for early atherosclerosis in anti-citrullinated protein antibodies positive individuals at risk for RA, a cross sectional study.
    Rheumatol Int. 2024;44:2007-2016.
    PubMed     Abstract available
    
    
    
67. NIELLY H, Biale L, Gilardin L, Carmoi T, et al
    Tocilizumab-induced psoriatic eruption : a case report and a case-based review.
    Rheumatol Int. 2024;44:2205-2212.
    PubMed     Abstract available
    
    
    September 2024
68. XIE W, Huang H, Geng Y, Fan Y, et al
    Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China.
    Rheumatol Int. 2024 Sep 12. doi: 10.1007/s00296-024-05713.
    PubMed     Abstract available
    
    
    
69. KOSCINSKA-SHUKLA I, Jaskolska M, Chylinska M, Jaskolski D, et al
    Elevated concentration of beta2-microglobulin among patients with carpal tunnel syndrome in the course of primary Sjogren syndrome - a prospective observational study on 50 patients.
    Rheumatol Int. 2024;44:1739-1747.
    PubMed     Abstract available
    
    
    
70. DE OLIVEIRA JL, Cordeiro RA, Guedes LKN, Pasoto SG, et al
    Shrinking lung syndrome in primary Sjogren's syndrome: a case-based review.
    Rheumatol Int. 2024;44:1795-1800.
    PubMed     Abstract available
    
    
    August 2024
71. TERMINE M, Davidson Z, Choi T, Leech M, et al
    What do we know about dietary perceptions and beliefs of patients with rheumatoid arthritis? A scoping review.
    Rheumatol Int. 2024 Aug 27. doi: 10.1007/s00296-024-05691.
    PubMed     Abstract available
    
    
    
72. SCHAFER VS, Winter L, Skowasch D, Bauer CJ, et al
    Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study.
    Rheumatol Int. 2024 Aug 21. doi: 10.1007/s00296-024-05685.
    PubMed     Abstract available
    
    
    
73. SAGTAGANOV Z, Bekaryssova D
    Complex rehabilitation of patients with rheumatoid arthritis.
    Rheumatol Int. 2024 Aug 3. doi: 10.1007/s00296-024-05669.
    PubMed     Abstract available
    
    
    July 2024
74. HERMANN S, Palmowski A, Hermann KGA, Muche B, et al
    Elevated uric acid is associated with a low bone mineral density in pre- but not post-menopausal women with rheumatoid arthritis: a pilot study.
    Rheumatol Int. 2024 Jul 29. doi: 10.1007/s00296-024-05655.
    PubMed     Abstract available
    
    
    
75. MAHAJAN A, Mruthyunjaya P, Padhee S, Ahmed S, et al
    People with osteoarthritis have a higher component of neuropathic pain as compared to those with rheumatoid arthritis: A cross-sectional study.
    Rheumatol Int. 2024 Jul 12. doi: 10.1007/s00296-024-05657.
    PubMed     Abstract available
    
    
    
76. SALEEM RA, Ramadan M, Elshaaer Y, Sukkarieh H, et al
    Laboratory features and pharmacological management of early and late-onset primary Sjogren's syndrome.
    Rheumatol Int. 2024;44:1317-1325.
    PubMed     Abstract available
    
    
    
77. ARYA PVA, Marnet E, Rondla M, Tan JW, et al
    Renal manifestations in adult-onset Still's disease: a systematic review.
    Rheumatol Int. 2024;44:1209-1218.
    PubMed     Abstract available
    
    
    
78. POPOVA V, Geneva-Popova M, Popova-Belova S, Doykov M, et al
    Diagnostic and prognostic role of serum interleukin-6 and carotid ultrasonography to detect subclinical atherosclerosis in patients with RA and ANCA-associated vasculitis.
    Rheumatol Int. 2024;44:1295-1303.
    PubMed     Abstract available
    
    
    
79. BOTABEKOVA A, Baimukhamedov C, Zimba O, Mehta P, et al
    Examining the clinical and radiological landscape of rhupus: navigating the challenges in disease classification.
    Rheumatol Int. 2024;44:1185-1196.
    PubMed     Abstract available
    
    
    
80. FEDORCHENKO Y, Zimba O, Yatsyshyn R, Doskaliuk B, et al
    The interplay between rheumatic diseases and pulmonary health.
    Rheumatol Int. 2024;44:1179-1184.
    PubMed     Abstract available
    
    
    
81. PASOTO SG, Villamarin LEB, de Vinci Kanda Kupa L, Deveza GBH, et al
    Assessment of hydroxychloroquine blood levels in Sjogren's disease patients: drug adherence and clinical associations.
    Rheumatol Int. 2024;44:1305-1315.
    PubMed     Abstract available
    
    
    June 2024
82. SERNA-PENA G, Flores-Gutierrez DP, Vega-Sevilla LF, Villarreal-Saenz MA, et al
    Sexual dysfunction and self-perceived sexual health in patients with rheumatoid arthritis and systemic lupus erythematosus: results from a cross-sectional survey.
    Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05648.
    PubMed     Abstract available
    
    
    
83. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D, Suigenbayev D, et al
    Managing rheumatoid arthritis and cardiovascular disease: the role of physical medicine and rehabilitation.
    Rheumatol Int. 2024 Jun 25. doi: 10.1007/s00296-024-05651.
    PubMed     Abstract available
    
    
    
84. BAKKER NF, van Weely SFE, Boonen A, Vliet Vlieland TPM, et al
    Work-related support for employed and self-employed people with rheumatoid arthritis or axial spondyloarthritis: a cross-sectional online survey of patients.
    Rheumatol Int. 2024 Jun 20. doi: 10.1007/s00296-024-05643.
    PubMed     Abstract available
    
    
    
85. RAMOS-PETERSEN L, Reinoso-Cobo A, Ortega-Avila AB, Garcia-Campos J, et al
    A clinical practice guideline for the management of the foot and ankle in rheumatoid arthritis.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05633.
    PubMed     Abstract available
    
    
    
86. SAGTAGANOV Z, Yessirkepov M, Bekaryssova D
    Yoga as a complementary therapy for rheumatoid arthritis: a case-based review.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05641.
    PubMed     Abstract available
    
    
    
87. CONTRERAS DG, McLane P, Barber CEH, Lin K, et al
    Emergency department utilization by persons with rheumatoid arthritis: a population-based cohort study.
    Rheumatol Int. 2024 Jun 8. doi: 10.1007/s00296-024-05627.
    PubMed     Abstract available
    
    
    
88. PETZINNA SM, Winter L, Skowasch D, Pizarro C, et al
    Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study.
    Rheumatol Int. 2024;44:1025-1034.
    PubMed     Abstract available
    
    
    May 2024
89. SWEENEY M, Adas MA, Cope A, Norton S, et al
    Longitudinal effects of affective distress on disease outcomes in rheumatoid arthritis: a meta-analysis and systematic review.
    Rheumatol Int. 2024 May 22. doi: 10.1007/s00296-024-05574.
    PubMed     Abstract available
    
    
    April 2024
90. KRAJEWSKA-WLODARCZYK M, Szelag M, Batko B, Zuber Z, et al
    Rheumatoid arthritis epidemiology: a nationwide study in Poland.
    Rheumatol Int. 2024 Apr 27. doi: 10.1007/s00296-024-05591.
    PubMed     Abstract available
    
    
    
91. PUROHIT R, Bhaskar N, Jehu T, Camargo Macias K, et al
    Patient-reported outcomes of curcumin supplementation in rheumatoid arthritis and psoriatic arthritis: a cross-sectional survey.
    Rheumatol Int. 2024 Apr 16. doi: 10.1007/s00296-024-05577.
    PubMed     Abstract available
    
    
    
92. LINDGREN LH, de Thurah A, Thomsen T, Hetland ML, et al
    Sociodemographic and clinical variables associated with negative illness perception in patients newly diagnosed with rheumatoid arthritis, axial spondyloarthritis, or psoriatic arthritis-a survey based cross-sectional study.
    Rheumatol Int. 2024 Apr 2. doi: 10.1007/s00296-024-05553.
    PubMed     Abstract available
    
    
    
93. FEDORCHENKO Y, Mahmudov K, Abenov Z, Zimba O, et al
    Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: unmet needs.
    Rheumatol Int. 2024;44:583-591.
    PubMed     Abstract available
    
    
    
94. ASMAR S, Messaykeh J, Hilal N, Rida MA, et al
    Drug persistence in patients with rheumatic and musculoskeletal diseases during a major economic crisis: results from a nationwide cross-sectional online survey.
    Rheumatol Int. 2024;44:725-736.
    PubMed     Abstract available
    
    
    March 2024
95. GRANT WB
    The present understanding of the effects of dietary red meat and the Mediterranean diet on rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 27. doi: 10.1007/s00296-024-05587.
    PubMed    
    
    
    
96. KALETA K, Krupa J, Suchy W, Sopel A, et al
    Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis.
    Rheumatol Int. 2024 Mar 24. doi: 10.1007/s00296-024-05556.
    PubMed     Abstract available
    
    
    
97. BAY LT, Nielsen DS, Flurey C, Giraldi A, et al
    Associations of gender with sexual functioning, loneliness, depression, fatigue and physical function amongst patients suffering from rheumatoid arthritis with a particular focus on methotrexate usage.
    Rheumatol Int. 2024 Mar 14. doi: 10.1007/s00296-024-05555.
    PubMed     Abstract available
    
    
    
98. SANTOS CS, Chen JP, Nikiphorou E, Tseng CW, et al
    Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study.
    Rheumatol Int. 2024 Mar 12. doi: 10.1007/s00296-024-05542.
    PubMed     Abstract available
    
    
    
99. LARKIN L, McKenna S, Pyne T, Comerford P, et al
    Promoting physical activity in rheumatoid arthritis through a physiotherapist led behaviour change-based intervention (PIPPRA): a feasibility randomised trial.
    Rheumatol Int. 2024 Mar 4. doi: 10.1007/s00296-024-05544.
    PubMed     Abstract available
    
    
    
100. DURUOZ MT, Nas K, Kasman SA, Oz N, et al
     Validity and reliability of the Duruoz Hand Index in patients with psoriatic arthritis.
     Rheumatol Int. 2024;44:535-542.
     PubMed     Abstract available
     
     
     
101. COSKUN BN, Yagiz B, Ocakoglu G, Dalkilic E, et al
     Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use.
     Rheumatol Int. 2024;44:509-515.
     PubMed     Abstract available
     
     
     
102. COX N, Hawarden A, Bajpai R, Farooq S, et al
     The relationship between pain and depression and anxiety in patients with inflammatory arthritis: a systematic review protocol.
     Rheumatol Int. 2024;44:435-440.
     PubMed     Abstract available
     
     
     
103. KAMINSKI M, Hrycaj P
     Celebrities influence on rheumatic diseases interest: a Google Trends analysis.
     Rheumatol Int. 2024;44:517-521.
     PubMed     Abstract available
     
     
     February 2024
104. SHARMA P, Brown S, Sokoya EM
     Re-evaluation of dietary interventions in rheumatoid arthritis: can we improve patient conversations around food choices?
     Rheumatol Int. 2024 Feb 20. doi: 10.1007/s00296-024-05541.
     PubMed     Abstract available
     
     
     January 2024
105. SCHAPINK L, den Broeder N, den Broeder AA, Verhoef LM, et al
     Treat-to-target vs fixed interval retreatment strategy with rituximab in rheumatoid arthritis: a retrospective cohort study.
     Rheumatol Int. 2024 Jan 29. doi: 10.1007/s00296-023-05524.
     PubMed     Abstract available
     
     
     
106. COUREL-IBANEZ J, Vetrovsky T, Ruzickova N, Maranon C, et al
     Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.
     Rheumatol Int. 2024 Jan 5. doi: 10.1007/s00296-023-05507.
     PubMed     Abstract available
     
     
     
107. MORALIYSKA R, Georgiev T, Bogdanova-Petrova S, Shivacheva T, et al
     Adoption rates of recommended vaccines and influencing factors among patients with inflammatory arthritis: a patient survey.
     Rheumatol Int. 2024;44:165-172.
     PubMed     Abstract available
     
     
     December 2023
108. DURUOZ MT, Ataman S, Bodur H, Cay HF, et al
     Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.
     Rheumatol Int. 2023 Dec 29. doi: 10.1007/s00296-023-05515.
     PubMed     Abstract available
     
     
     
109. DUBEY S, Woodhead F
     Survival differences in rheumatoid arthritis interstitial lung disease and idiopathic pulmonary fibrosis may be explained by delays in presentation: results from multivariate analysis in a monocentric UK study.
     Rheumatol Int. 2023 Dec 12. doi: 10.1007/s00296-023-05505.
     PubMed     Abstract available
     
     
     November 2023
110. TEUWEN MMH, Vlieland TPMV, van Weely SFE, Schoones JW, et al
     Quality of reporting and nature of harms in clinical trials on supervised exercise in patients with rheumatoid arthritis or axial spondyloarthritis.
     Rheumatol Int. 2023 Nov 30. doi: 10.1007/s00296-023-05502.
     PubMed     Abstract available
     
     
     
111. TEUWEN MMH, van Weely SFE, Vliet Vlieland TPM, Douw T, et al
     Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study.
     Rheumatol Int. 2023 Nov 25. doi: 10.1007/s00296-023-05487.
     PubMed     Abstract available
     
     
     
112. MIHAYLOVA V, Kazakova M, Batalov Z, Karalilova R, et al
     JAK inhibitors improve ATP production and mitochondrial function in rheumatoid arthritis: a pilot study.
     Rheumatol Int. 2023 Nov 20. doi: 10.1007/s00296-023-05501.
     PubMed     Abstract available
     
     
     
113. DE FIGUEIREDO LQ, de Andrade Lopes FO, Franco AS, Giardini HAM, et al
     Scleromalacia perforans as an early manifestation of late-onset rheumatoid arthritis: a case-based review.
     Rheumatol Int. 2023 Nov 4. doi: 10.1007/s00296-023-05494.
     PubMed     Abstract available
     
     
     
114. BEKARYSSOVA D, Yessirkepov M, Mahmudov K
     Structure, demography, and medico-social characteristics of articular syndrome in rheumatic diseases: a retrospective monocentric analysis of 2019-2021 data.
     Rheumatol Int. 2023;43:2057-2064.
     PubMed     Abstract available
     
     
     
115. MAYER M, Martinic M, Reihl-Crnogaj M, Anic B, et al
     The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjogren's syndrome: a single-centre, retrospective cohort study.
     Rheumatol Int. 2023;43:2031-2036.
     PubMed     Abstract available
     
     
     October 2023
116. COSKUN BENLIDAYI I
     Exercise therapy for improving cardiovascular health in rheumatoid arthritis.
     Rheumatol Int. 2023 Oct 31. doi: 10.1007/s00296-023-05492.
     PubMed     Abstract available
     
     
     
117. KOUNATIDIS DC, Papadimitropoulos V, Avramidis K, Plenga E, et al
     Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review.
     Rheumatol Int. 2023 Oct 18. doi: 10.1007/s00296-023-05483.
     PubMed     Abstract available
     
     
     
118. FLOURI I, Goutakoli P, Repa A, Bertsias A, et al
     Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
     Rheumatol Int. 2023 Oct 10. doi: 10.1007/s00296-023-05455.
     PubMed     Abstract available
     
     
     
119. THOMSEN T, Aadahl M, Hetland ML, Esbensen BA, et al
     Physical activity guidance in the rheumatology clinic-what matters for patients with rheumatoid arthritis? A qualitative study.
     Rheumatol Int. 2023 Oct 3. doi: 10.1007/s00296-023-05466.
     PubMed     Abstract available
     
     
     September 2023
120. NEYCHEVA S, Naseva E, Batalov Z, Karalilova R, et al
     First multi-center retrospective study assessed the compliance with and persistence of biological therapies in Bulgarian population with rheumatoid arthritis.
     Rheumatol Int. 2023 Sep 30. doi: 10.1007/s00296-023-05458.
     PubMed     Abstract available
     
     
     
121. SULLI A, Clini P, Bruzzone G, Signori A, et al
     An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study.
     Rheumatol Int. 2023 Sep 13. doi: 10.1007/s00296-023-05444.
     PubMed     Abstract available
     
     
     
122. AMEZCUA-GUERRA LM, Carbonell-Bobadilla N, Soto-Fajardo C, Vargas A, et al
     Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis.
     Rheumatol Int. 2023 Sep 11. doi: 10.1007/s00296-023-05445.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge.